PL3057571T3 - Kompozycje w postaci pasty zawierającej inhibitor pompy protonowej - Google Patents
Kompozycje w postaci pasty zawierającej inhibitor pompy protonowejInfo
- Publication number
- PL3057571T3 PL3057571T3 PL13783629T PL13783629T PL3057571T3 PL 3057571 T3 PL3057571 T3 PL 3057571T3 PL 13783629 T PL13783629 T PL 13783629T PL 13783629 T PL13783629 T PL 13783629T PL 3057571 T3 PL3057571 T3 PL 3057571T3
- Authority
- PL
- Poland
- Prior art keywords
- proton pump
- pump inhibitor
- paste compositions
- inhibitor paste
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 229940126409 proton pump inhibitor Drugs 0.000 title 1
- 239000000612 proton pump inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13783629.2A EP3057571B1 (en) | 2013-10-18 | 2013-10-18 | Proton pump inhibitor paste compositions |
| PCT/GB2013/052730 WO2015055974A1 (en) | 2013-10-18 | 2013-10-18 | Proton pump inhibitor paste compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3057571T3 true PL3057571T3 (pl) | 2019-07-31 |
Family
ID=49510431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13783629T PL3057571T3 (pl) | 2013-10-18 | 2013-10-18 | Kompozycje w postaci pasty zawierającej inhibitor pompy protonowej |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3057571B1 (pl) |
| DK (1) | DK3057571T3 (pl) |
| ES (1) | ES2717029T3 (pl) |
| PL (1) | PL3057571T3 (pl) |
| WO (1) | WO2015055974A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017310506B2 (en) | 2016-08-11 | 2019-11-21 | Dmk Pharmaceuticals Corporation | Drug compositions |
| EP3299017A1 (en) * | 2016-09-23 | 2018-03-28 | The Boots Company PLC | Formulation |
| EP3720844A4 (en) | 2017-12-08 | 2021-08-11 | Adamis Pharmaceuticals Corporation | MEDICINAL COMPOSITIONS |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0008403A (pt) * | 1999-02-23 | 2002-01-29 | Merck & Co Inc | Formulação farmacêutica para administração oral |
| TWI232761B (en) * | 2000-07-01 | 2005-05-21 | Pharmaceutical Ind Tech & Dev | Capsule preparation for oral administration and the preparation method thereof |
| WO2005000269A1 (en) * | 2003-06-26 | 2005-01-06 | Cipla Limited | Pharmaceutical formulations comprising a proton pump inhibitor |
-
2013
- 2013-10-18 EP EP13783629.2A patent/EP3057571B1/en active Active
- 2013-10-18 ES ES13783629T patent/ES2717029T3/es active Active
- 2013-10-18 PL PL13783629T patent/PL3057571T3/pl unknown
- 2013-10-18 WO PCT/GB2013/052730 patent/WO2015055974A1/en not_active Ceased
- 2013-10-18 DK DK13783629.2T patent/DK3057571T3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2717029T3 (es) | 2019-06-18 |
| DK3057571T3 (en) | 2019-04-15 |
| EP3057571B1 (en) | 2019-03-06 |
| EP3057571A1 (en) | 2016-08-24 |
| WO2015055974A1 (en) | 2015-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL295091B1 (en) | Solid solution mixtures | |
| GB201304662D0 (en) | Compositions | |
| SG11201508091PA (en) | Power manager | |
| SG11201602596UA (en) | Stabilized efinaconazole compositions | |
| SI3008346T1 (sl) | Črpalka | |
| SG11201504466UA (en) | Cooling-equipment working-fluid composition | |
| FI3051945T3 (fi) | Fungisidiset koostumukset | |
| GB201313615D0 (en) | Compositions | |
| EP3042540A4 (en) | Electrothermic compositions | |
| EP2988755A4 (en) | RETICULATED HYALURONIC ACID COMPOSITIONS | |
| EP3056733C0 (en) | PUMP | |
| PL2964958T3 (pl) | Pompy | |
| GB201305090D0 (en) | Pump | |
| GB201305997D0 (en) | Cathode | |
| ZA201505650B (en) | New compositions | |
| IL241040A0 (en) | Liquid formulations of rascadotril | |
| GB201320962D0 (en) | Compositions | |
| GB201316463D0 (en) | Novel compositions | |
| PL3057571T3 (pl) | Kompozycje w postaci pasty zawierającej inhibitor pompy protonowej | |
| GB201311172D0 (en) | Pump | |
| GB201306720D0 (en) | Formulation | |
| GB201316199D0 (en) | Offer terminal | |
| GB2524351B (en) | Proton Pump Inhibitor Paste Compositions | |
| GB201320959D0 (en) | Compositions | |
| EP3014120A4 (en) | Metering pump |